Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
I
Indraprastha Medical Corporation Ltd
Score 68/100• Decent
Indraprastha Medical Corporation Ltd shows potential but faces challenges in growth consistency and profitability metrics. Caution is advised.
Company’s Health82/100
Valuation 20/100 · PB 9.3174
Technical Momentum
1M 31.812% 6M 53.863% 1Y 49.115%
Confidence100%
Low leverage (D/E)No promoter pledge
#61
View details ➜
E
Emcure Pharmaceuticals Ltd
Score 68/100• Decent
Emcure Pharmaceuticals shows potential for growth, but faces several challenges that could impact its performance.
Company’s Health85/100
Valuation 20/100 · PB 5.3865
Technical Watch
1M 6.183% 6M 29.266% 1Y -8.352%
Confidence100%
Low leverage (D/E)Decent revenue growth
Promoter pledge present
#62
View details ➜
P
PREVEST DENPRO LTD
Score 68/100• Decent
The stock shows potential but faces challenges in growth consistency and valuation metrics.
Company’s Health98/100
Valuation 20/100 · PB 5.9628
Technical Avoid
1M -1.933% 6M 12.026% 1Y -4.991%
Confidence100%
Low leverage (D/E)No promoter pledge
#63
View details ➜
P
Parnax Lab Ltd
Score 68/100• Decent
Parnax Lab Ltd shows potential in a growing sector but faces significant challenges in growth consistency and profitability metrics.
Company’s Health63/100
Valuation 80/100 · PB 1.78
Technical Avoid
1M -4.853% 6M 40.217% 1Y -11.432%
Confidence100%
Reasonable PB valuation
Promoter pledge presentThin margins
#64
View details ➜
O
Omkar Pharmachem Ltd
Score 68/100• Decent
Omkar Pharmachem Ltd shows potential but faces several challenges that may hinder growth.
Company’s Health68/100
Valuation 60/100 · PB 2.9998
Technical Avoid
1M 4.775% 6M -6.5% 1Y 0.972%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#65
View details ➜
M
Medicamen Organics Ltd
Score 68/100• Decent
Medicamen Organics Ltd shows potential for growth but faces several challenges that could impact its performance.
Company’s Health94/100
Valuation 80/100 · PB 1.2821
Technical Watch
1M 5.714% 6M 20.144% 1Y -38.148%
Confidence100%
Low leverage (D/E)No promoter pledge
#66
View details ➜
M
Medicamen Biotech Ltd
Score 68/100• Decent
Medicamen Biotech Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
Company’s Health62/100
Valuation 60/100 · PB 2.3959
Technical Avoid
1M 22.521% 6M -12.983% 1Y -29.818%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#67
View details ➜
M
Medi-Caps Ltd
Score 68/100• Decent
Medi-Caps Ltd shows potential but faces challenges in growth and profitability metrics. Caution is advised.
Company’s Health51/100
Valuation 100/100 · PB 0.401
Technical Avoid
1M 4.474% 6M -6.921% 1Y -28.949%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#68
View details ➜
M
Medi Assist Healthcare Services Ltd
Score 68/100• Decent
Medi Assist Healthcare Services Ltd shows potential for growth, but faces challenges in profitability and valuation metrics.
Company’s Health79/100
Valuation 20/100 · PB 7.6675
Technical Watch
1M 6.267% 6M 29.556% 1Y -7.782%
Confidence100%
Low leverage (D/E)No promoter pledge
#69
View details ➜
I
Indegene Ltd
Score 68/100• Decent
Indegene Ltd shows potential for growth in a future-ready sector, but faces challenges in profitability consistency and valuation metrics.
Company’s Health80/100
Valuation 20/100 · PB 5.2812
Technical Avoid
1M 0.802% 6M 6.526% 1Y -13.298%
Confidence100%
Low leverage (D/E)No promoter pledge
#70
View details ➜
F
Fredun Pharmaceuticals Ltd
Score 68/100• Decent
Fredun Pharmaceuticals Ltd shows potential for growth but carries risks that need to be monitored closely.
Company’s Health72/100
Valuation 20/100 · PB 5.9828
Technical Watch
1M 20.253% 6M 119.408% 1Y 117.948%
Confidence100%
No promoter pledgeDecent revenue growth
Thin margins
#71
View details ➜
B
Bajaj Healthcare Ltd
Score 68/100• Decent
Bajaj Healthcare Ltd shows potential in a growing sector, but inconsistencies in growth and profitability metrics warrant caution.
Company’s Health67/100
Valuation 40/100 · PB 3.2219
Technical Avoid
1M -1.09% 6M -7.821% 1Y 32.006%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#72
View details ➜
A
Anuh Pharma Ltd
Score 68/100• Decent
Anuh Pharma Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should proceed with caution.
Company’s Health87/100
Valuation 60/100 · PB 2.5601
Technical Avoid
1M 5.613% 6M 6.814% 1Y -6.521%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#73
View details ➜
K
Kilitch Drugs (India) Ltd
Score 68/100• Decent
Kilitch Drugs shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health86/100
Valuation 40/100 · PB 3.3865
Technical Avoid
1M 13.681% 6M 1.756% 1Y 23.745%
Confidence100%
Low leverage (D/E)No promoter pledge
#74
View details ➜
G
Gujarat Terce Laboratories Ltd
Score 68/100• Decent
Gujarat Terce Laboratories Ltd shows decent potential but faces challenges in profitability and valuation. Investors should proceed with caution.
Company’s Health33/100
Valuation 20/100 · PB 5.2389
Technical Avoid
1M 1.726% 6M -17.508% 1Y -48.064%
Confidence100%
Low leverage (D/E)
Weak ROEPromoter pledge present
#75
View details ➜
Showing 61 to 75 of 301 (21 Pages)